BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 398530)

  • 1. Evaluation of mutagenicity of metronidazole and mizonidazole on the base of lambda prophage induction and Ames test.
    Gałkiewicz E; Pyziak M; Chomiczewski J; Górski T
    Radiobiol Radiother (Berl); 1979 Oct; 20(5):657-60. PubMed ID: 398530
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic activity of radiosensitizers.
    Grzybowska E; Kalinowska E; Szala S
    Acta Microbiol Pol; 1985; 34(2):111-20. PubMed ID: 2412398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of procarbazine (MIH) on the induction of prophage lambda in Escherichia coli K12 and toxic effects on Salmonella typhimurium.
    Lackner F; Schüpbach ME
    Mutat Res; 1981 Nov; 90(3):247-54. PubMed ID: 6460182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prophage induction and mutagenicity in Ames tester strains by alkylating agents.
    Wheeler L; Halula M; DeMeo M
    Proc West Pharmacol Soc; 1979; 22():261-4. PubMed ID: 390539
    [No Abstract]   [Full Text] [Related]  

  • 5. [Toxic and radiosensitizing effect of reduced nitroimidazoles on E. coli B/r cells].
    Riabchenko NI; Semin IuA; Petrova KM; Kutmin AI
    Radiobiologiia; 1983; 23(4):505-9. PubMed ID: 6351162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metronidazole and misonidazole on some metabolic parameters of normal tissues in mice.
    Bara A; Mustea I
    Radiobiol Radiother (Berl); 1980; 21(4):453-8. PubMed ID: 7455028
    [No Abstract]   [Full Text] [Related]  

  • 7. On the mutagenicity of nitroimidazoles.
    Voogd CE
    Mutat Res; 1981 May; 86(3):243-77. PubMed ID: 6457989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the anticholinesterase activity of metronidazole and misonidazole.
    Von Burg R; Conroy PJ
    Eur J Pharmacol; 1979 May; 55(4):417-20. PubMed ID: 467496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutagenic action of nitroimidazoles. I. Metronidazole, nimorazole, dimetridazole and ronidazole.
    Voogd CE; Van der Stel JJ; Jacobs JJ
    Mutat Res; 1974 Dec; 26(6):483-90. PubMed ID: 4610373
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA damage induced by reductively activated nitroimidazoles--pH effects.
    Edwards DI; Knight RC; Zahoor A
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1207-9. PubMed ID: 3528090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.
    Lindmark DG; Müller M
    Antimicrob Agents Chemother; 1976 Sep; 10(3):476-82. PubMed ID: 791102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity evaluation of KB-944, a new calcium antagonist, in the Ames bacterial system.
    Tanaka H; Tanaka A; Tsunetoshi Y; Sotomura M; Nose T
    Arzneimittelforschung; 1982; 32(9):1087-8. PubMed ID: 6756416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.
    Mahood JS; Willson RL
    Br J Cancer; 1981 Mar; 43(3):350-4. PubMed ID: 7225286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo.
    Basag SH; Dunlop JR; Searle AJ; Willson RL
    Br J Cancer Suppl; 1978 Jun; 3():132-5. PubMed ID: 354677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo investigation of the radiosensitization of metastases by nitroimidazoles.
    Davies BM; Watling DC
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):809-19. PubMed ID: 711550
    [No Abstract]   [Full Text] [Related]  

  • 16. The organospecific activity of metronidazole and azanidazole in the intrasanguineous host-mediated assay.
    Cantelli-Forti G; Hrelia P; Paolini M; Bronzetti G; Biagi GL
    Drugs Exp Clin Res; 1985; 11(11):755-9. PubMed ID: 3915465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic activities of simple nitrofuran derivatives. I. Comparison of related compounds in the phage inductest, chloroplast-bleaching and bacterial-repair and mutagenicity tests.
    Soska J; Koukalová B; Ebringer L
    Mutat Res; 1981 Mar; 81(1):21-6. PubMed ID: 6454838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophage induction and mutagenicity of a series of anti-tumour platinum(II) and platinum(IV) co-ordination complexes.
    Mattern IE; Cocchiarella L; van Kralingen CG; Lohman PH
    Mutat Res; 1982 Aug; 95(2-3):79-93. PubMed ID: 6214710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory effects and ascorbate reactions with misonidazole and other recently developed drugs.
    Jacobson B; Biaglow JE; Fielden EM; Adams GE
    Cancer Clin Trials; 1980; 3(1):47-53. PubMed ID: 7389037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression by hypoxic cell radiosensitizers: a phenomenon of potential clinical importance.
    Rockwell S; Kapp DS
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1071-3. PubMed ID: 7050051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.